Thomas W Dubensky Net Worth & Insider Trades

Thomas W Dubensky - President, Tempest Therapeutics, Inc

As of January 5, 2023

What is Thomas W Dubensky's Net Worth?

The current estimated net worth of Tempest Therapeutics, Inc's President, Thomas W Dubensky, is estimated to be about $7.9M . Thomas W Dubensky owns about 113,343 units of Tempest Therapeutics, Inc common stock. In the last 2 years at Tempest Therapeutics, Inc, Thomas W Dubensky has sold an estimated value of $0 worth.

What is Thomas W Dubensky's Past Insider Trading?

Thomas W Dubensky's largest purchase order was 2,000 units , worth over $9.56K on January 11, 2022. In total, Thomas W Dubensky has made about 5 transactions over 2 years of their time at Tempest Therapeutics, Inc. Thomas W Dubensky usually trades in January, with the busiest year in 2022.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Thomas W Dubensky

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Thomas W Dubensky's' Mailing Address?

  • Mailing address is C/o Aduro Biotech, Inc. 740 Heinz Avenue Berkeley CA 94710 CA

What are Tempest Therapeutics, Inc's Past Insider Trades?

Tempest Therapeutics, Inc's most recent insider trade came on May 3, 2022 by Thomas Woiwode who bought 2,118,644 units worth $5M . In the last 4 months, insiders at Tempest Therapeutics, Inc have bought an estimated value of $0 worth of shares. Insider trading is most common in June, with the busiest year in 2022. The most active traders at the company are Samuel Whiting, Chief Medical Officer,  Thomas W Dubensky, President,  and Michael Raab, Director .

Tempest Therapeutics, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...